{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:29:38Z","timestamp":1780612178927,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T00:00:00Z","timestamp":1487030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/bjc.2017.20","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T21:02:11Z","timestamp":1487106131000},"page":"703-708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma"],"prefix":"10.1038","volume":"116","author":[{"given":"Sanjeevan","family":"Muruganandan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helman","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Shilkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nola","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"de Klerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AW","family":"Musk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Brims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"issue":"10","key":"BFbjc201720_CR1","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1445-2197.2009.05060.x","volume":"79","author":"JM Alvarez","year":"2009","unstructured":"Alvarez JM, Hasani A, Segal A, Sterret G, Millward M, Nowak A, Musk W, Bydder S (2009) Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy. ANZ J Surg 79 (10): 734\u2013738.","journal-title":"ANZ J Surg"},{"issue":"2","key":"BFbjc201720_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jtho.2015.10.003","volume":"11","author":"A Bill\u00e9","year":"2015","unstructured":"Bill\u00e9 A, Krug LM, Woo KM, Rusch VW, Zauderer MG (2015) Contemporary analysis of prognostic factors in patients with unresectable malignant pleural mesothelioma. J Thorac Oncol 11 (2): 249\u2013255.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"BFbjc201720_CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jrnms-95-4","volume":"95","author":"FJ Brims","year":"2009","unstructured":"Brims FJ (2009) Asbestos\u2014a legacy and a persistent problem. J R Nav Med Serv 95 (1): 4\u201311.","journal-title":"J R Nav Med Serv"},{"issue":"2","key":"BFbjc201720_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s13665-013-0045-1","volume":"2","author":"FJ Brims","year":"2013","unstructured":"Brims FJ, Maskell NA (2013) Prognostic factors for malignant pleural mesothelioma. Curr Respir Care Rep 2 (2): 100\u2013108.","journal-title":"Curr Respir Care Rep"},{"issue":"4","key":"BFbjc201720_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","volume":"11","author":"FJ Brims","year":"2016","unstructured":"Brims FJ, Meniawy TM, Duffus I, de Fonseka D, Segal A, Creaney J, Maskell N, Lake RA, de Klerk N, Nowak AK (2016) A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis. J Thorac Oncol 11 (4): 573\u2013582.","journal-title":"J Thorac Oncol"},{"issue":"Suppl 2","key":"BFbjc201720_CR6","first-page":"ii1","volume":"62","author":"British Thoracic Society Standards of Care C","year":"2007","unstructured":"British Thoracic Society Standards of Care C (2007) BTS statement on malignant mesothelioma in the UK, 2007. Thorax 62 (Suppl 2): ii1\u2013ii19.","journal-title":"Thorax"},{"issue":"5","key":"BFbjc201720_CR7","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.athoracsur.2004.05.007","volume":"78","author":"R Bueno","year":"2004","unstructured":"Bueno R, Reblando J, Glickman J, Jaklitsch MT, Lukanich JM, Sugarbaker DJ (2004) Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg 78 (5): 1774\u20131776.","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"BFbjc201720_CR8","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1097\/00000478-200009000-00001","volume":"24","author":"A Churg","year":"2000","unstructured":"Churg A, Colby TV, Cagle P, Corson J, Gibbs AR, Gilks B, Grimes M, Hammar S, Roggli V, Travis WD (2000) The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol 24 (9): 1183\u20131200.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"BFbjc201720_CR9","first-page":"749","volume":"73","author":"P Franklin","year":"2016","unstructured":"Franklin P, Alfonso H, Reid A, Olsen N, Shilkin KB, Brims F, de Klerk N, Musk AW (2016) Asbestos exposure and histological subtype of malignant mesothelioma. Occup Environ Med 73 (11): 749\u2013752.","journal-title":"Occup Environ Med"},{"issue":"3","key":"BFbjc201720_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cyt.12250","volume":"26","author":"A Hjerpe","year":"2015","unstructured":"Hjerpe A, Ascoli V, Bedrossian CW, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Onder S, Segal A, Vielh P (2015) Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: a secondary publication. Cytopathology 26 (3): 142\u2013156.","journal-title":"Cytopathology"},{"issue":"5","key":"BFbjc201720_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","volume":"137","author":"AN Husain","year":"2013","unstructured":"Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M International Mesothelioma Interest G (2013) Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 137 (5): 647\u2013667.","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"BFbjc201720_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","volume":"40","author":"HC Hwang","year":"2016","unstructured":"Hwang HC, Sheffield BS, Rodriguez S, Thompson K, Tse CH, Gown AM, Churg A (2016) Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens. Am J Surg Pathol 40 (1): 120\u2013126.","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"BFbjc201720_CR13","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.lungcan.2005.03.002","volume":"49","author":"L Kazan-Allen","year":"2005","unstructured":"Kazan-Allen L (2005) Asbestos and mesothelioma: worldwide trends. Lung Cancer 49 (Suppl 1): S3\u2013S8.","journal-title":"Lung Cancer"},{"issue":"5","key":"BFbjc201720_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ajim.4700210512","volume":"21","author":"AW Musk","year":"1992","unstructured":"Musk AW, de Klerk N, Eccles JL, Hobbs MS, Armstrong BK, Layman L, McNulty JC (1992) Wittenoom, Western Australia: a modern industrial disaster. Am J Ind Med 21 (5): 735\u2013747.","journal-title":"Am J Ind Med"},{"issue":"6","key":"BFbjc201720_CR15","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1183\/09031936.00000811","volume":"38","author":"AW Musk","year":"2011","unstructured":"Musk AW, Olsen N, Alfonso H, Reid A, Mina R, Franklin P, Sleith J, Hammond N, Threlfall T, Shilkin KB, de Klerk N (2011) Predicting survival in malignant mesothelioma. Eur Respir J 38 (6): 1420\u20131424.","journal-title":"Eur Respir J"},{"issue":"5","key":"BFbjc201720_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5694\/mja11.10125","volume":"195","author":"NJ Olsen","year":"2011","unstructured":"Olsen NJ, Franklin PJ, Reid A, de Klerk NH, Threlfall TJ, Shilkin K, Musk B (2011) Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation. Med J Aust 195 (5): 271\u2013274.","journal-title":"Med J Aust"},{"issue":"3","key":"BFbjc201720_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/JTO.0b013e31823e0667","volume":"7","author":"V Pinelli","year":"2012","unstructured":"Pinelli V, Laroumagne S, Sakr L, Marchetti GP, Tassi GF, Astoul P (2012) Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma. J Thorac Oncol 7 (3): 595\u2013598.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"BFbjc201720_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/dc.21303","volume":"38","author":"EA Rakha","year":"2010","unstructured":"Rakha EA, Patil S, Abdulla K, Abdulkader M, Chaudry Z, Soomro IN (2010) The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Diagn Cytopathol 38 (12): 874\u2013879.","journal-title":"Diagn Cytopathol"},{"issue":"9","key":"BFbjc201720_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1136\/thoraxjnl-2013-204161","volume":"69","author":"A Reid","year":"2014","unstructured":"Reid A, de Klerk NH, Magnani C, Ferrante D, Berry G, Musk AW, Merler E (2014) Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis. Thorax 69 (9): 843\u2013850.","journal-title":"Thorax"},{"issue":"1","key":"BFbjc201720_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1378\/chest.111.1.106","volume":"111","author":"AA Renshaw","year":"1997","unstructured":"Renshaw AA, Dean BR, Antman KH, Sugarbaker DJ, Cibas ES (1997a) The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest 111 (1): 106\u2013109.","journal-title":"Chest"},{"issue":"2","key":"BFbjc201720_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/ajcp\/107.2.206","volume":"107","author":"AA Renshaw","year":"1997","unstructured":"Renshaw AA, Nappi D, Swanson S, Sugarbaker DJ (1997b) Effusion cytology after extrapleural pneumonectomy for treatment of malignant mesothelioma. Am J Clin Pathol 107 (2): 206\u2013210.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"BFbjc201720_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAT.0b013e32835bc848","volume":"45","author":"A Segal","year":"2013","unstructured":"Segal A, Sterrett GF, Frost FA, Shilkin KB, Olsen NJ, Musk AW, Nowak AK, Robinson BW, Creaney J (2013) A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit. Pathology 45 (1): 44\u201348.","journal-title":"Pathology"},{"issue":"Suppl 2","key":"BFbjc201720_CR23","doi-asserted-by":"crossref","first-page":"ii43","DOI":"10.1093\/annonc\/mdn083","volume":"19","author":"RA Stahel","year":"2008","unstructured":"Stahel RA, Weder W, Felip E Group EGW (2008) Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 (Suppl 2): ii43\u2013ii44.","journal-title":"Ann Oncol"},{"issue":"14","key":"BFbjc201720_CR24","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (14): 2636\u20132644.","journal-title":"J Clin Oncol"},{"issue":"7","key":"BFbjc201720_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/dc.23491","volume":"44","author":"AE Walts","year":"2016","unstructured":"Walts AE, Hiroshima K, McGregor SM, Wu D, Husain AN, Marchevsky AM (2016) BAP1 immunostain and CDKN2A (p16) FISH analysis: clinical applicability for the diagnosis of malignant mesothelioma in effusions. Diagn Cytopathol 44 (7): 599\u2013606.","journal-title":"Diagn Cytopathol"},{"key":"BFbjc201720_CR26","unstructured":"WHO (2010) World health organisation mortality database http:\/\/www.who.int\/healthinfo\/statistics\/mortality_rawdata\/en\/index.html (accessed 9 January 2014)."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc201720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc201720","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc201720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:38:26Z","timestamp":1684417106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc201720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFbjc201720"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2017.20","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]},"assertion":[{"value":"5 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}